Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
Hongcheng Yang, Ruoyang Shao, Hongxin Huang, et al.
Cancer Medicine (2019) Vol. 8, Iss. 9, pp. 4245-4253
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia, Lang Rao, Huimin Yao, et al.
Advanced Materials (2020) Vol. 32, Iss. 40
Closed Access | Times Cited: 711
Stealth Coating of Nanoparticles in Drug-Delivery Systems
See Yee Fam, Chin Fei Chee, Chean Yeah Yong, et al.
Nanomaterials (2020) Vol. 10, Iss. 4, pp. 787-787
Open Access | Times Cited: 304
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 293
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Jing Gao, Yuanzheng Liang, Liang Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 288
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Clément Anfray, Aldo Ummarino, Fernando Torres, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 46-46
Open Access | Times Cited: 259
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Elena Martín‐Orozco, Ana Sanchez-Fernandez, Irene Ortiz-Parra, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 237
CAR-macrophage: A new immunotherapy candidate against solid tumors
Yizhao Chen, Zhiying Yu, Xuewen Tan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111605-111605
Open Access | Times Cited: 164
Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
Tiffany D. Ricketts, Néstor Prieto‐Domínguez, Pramod S. Gowda, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 131
Senescent cells and macrophages: key players for regeneration?
Sonia S. Elder, Elaine Emmerson
Open Biology (2020) Vol. 10, Iss. 12
Open Access | Times Cited: 75
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
Jennifer Sun, Barbara Muz, Kinan Alhallak, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 305-305
Open Access | Times Cited: 71
New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials
Haoer Jin, Sha Qin, Jiang He, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2775-2794
Open Access | Times Cited: 45
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
Guo‐Qiang Zhang, Xi Chen, Ning Ju, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1953-1969
Open Access | Times Cited: 9
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing
Cristina Belgiovine, Elisabeth Digifico, Clément Anfray, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3226-3226
Open Access | Times Cited: 63
Targeting tumor‐associated macrophages: A potential treatment for solid tumors
Yibing Chen, Xin Jin, Yucen Song, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 5, pp. 3445-3465
Closed Access | Times Cited: 56
Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
Amy J. Petty, Dwight H. Owen, Yiping Yang, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5318-5318
Open Access | Times Cited: 54
Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities
Margot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 8
The unique immune microenvironment of liver metastases: Challenges and opportunities
Aaron Ciner, Keaton Jones, Ruth J. Muschel, et al.
Seminars in Cancer Biology (2020) Vol. 71, pp. 143-156
Closed Access | Times Cited: 50
Cancer Therapy Targeting CD47/SIRPα
Nazlı Dizman, Elizabeth I. Buchbinder
Cancers (2021) Vol. 13, Iss. 24, pp. 6229-6229
Open Access | Times Cited: 35
Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment
Rongjuan Wang, Chang Zhang, Yuting Cao, et al.
Theranostics (2022) Vol. 13, Iss. 1, pp. 148-160
Open Access | Times Cited: 25
Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems
Cuiping Zhan, Ying Jin, Xinzhi Xu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11049-11072
Open Access | Times Cited: 15
Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma
Lin Chen, Yidian Chu, Zheng Ye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy
Cong-Shan Yuan, Ya Liu, Ting Wang, et al.
ACS Biomaterials Science & Engineering (2020) Vol. 6, Iss. 9, pp. 4774-4798
Closed Access | Times Cited: 34
Recent progress of macrophage vesicle-based drug delivery systems
Wenjie Xu, Jiaxin Cai, Yongjiang Li, et al.
Drug Delivery and Translational Research (2022) Vol. 12, Iss. 10, pp. 2287-2302
Closed Access | Times Cited: 20
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
Xuejia Kang, Yongzhuo Huang, Huiyuan Wang, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 61-61
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top